[1]
Morales, J.C. et al. 2023. A Case of Catastrophic Atypical Hemolytic Uremic Syndrome Unresponsive to Eculizumab and the use of Ravulizumab Off-label. Journal of Clinical Nephrology. 7, 3 (Oct. 2023), 073–077. DOI:https://doi.org/10.29328/journal.jcn.1001113.